United States · 
Who invested in Nitrase Therapeutics?
Nitrase Therapeutics's investors include Sofinnova Partners, Alexandria Venture Investments and AbbVie.
United States · Series A startup
Who invested in Nitrase Therapeutics
Funding summaryUpdated 26 Oct 2026
$7.0Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $7.0MNov 2021
- Investors
- 3
The rounds
- Nov 2021
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nitrase Therapeutics
How much has Nitrase Therapeutics raised?
Nitrase Therapeutics has raised $7.0M across 1 round since 2021.
When did Nitrase Therapeutics last raise?
Nitrase Therapeutics's most recent round was a Series A of $7.0M in Nov 2021.
What was Nitrase Therapeutics's biggest round?
Its most recent round, $7.0M in Nov 2021, is also its largest on record.
Who backed Nitrase Therapeutics first?
Nitrase Therapeutics's first round on record, in Nov 2021, was backed by Sofinnova Partners, Alexandria Venture Investments and AbbVie.
What stage is Nitrase Therapeutics at?
Nitrase Therapeutics's latest named round is a Series A, in Nov 2021.
Where is Nitrase Therapeutics based?
Nitrase Therapeutics is based in the United States.
Companies like Nitrase Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.